Alvotech – Iceland

Alvotech was founded in 2013, with the clear mission to become a global leader in Biogenerics, defined as differentiated, high-quality, cost-controlled biosimilars. We have pursued this goal by creating a fully-integrated specialty company in control of every value-adding development step from cell line development to commercial manufacturing of the Product.
Our in-house development and manufacturing platform located at four sites across Europe drives timely development of a strong and differentiated portfolio, while our state-of-the-art flexible manufacturing facility, located in Reykjavik Iceland, ensures high quality and cost-effective production.